[HTML][HTML] Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities

W Jiang, WL Jin, AM Xu - International Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Cholesterol is crucial for cell survival and growth, and dysregulation of cholesterol
homeostasis has been linked to the development of cancer. The tumor microenvironment …

Itraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer

Y Zhang, L Li, F Chu, H Wu, X Xiao, J Ye… - Cancer Science, 2024 - Wiley Online Library
Advanced colorectal cancer (CRC) is characterized by a high recurrence and metastasis
rate, which is the primary cause of patient mortality. Unfortunately, effective anti‐cancer …

In silico identification of modulators of J domain protein-Hsp70 interactions in Plasmodium falciparum: a drug repurposing strategy against malaria

H Singh, SY Almaazmi, T Dutta, RA Keyzers… - Frontiers in Molecular …, 2023 - frontiersin.org
Plasmodium falciparum is a unicellular, intracellular protozoan parasite, and the causative
agent of malaria in humans, a deadly vector borne infectious disease. A key phase of …

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways

MR MacLean, OL Walker, RP Arun… - International Journal of …, 2024 - mdpi.com
Cancer stem cells (CSCs) represent a subpopulation within tumors that promote cancer
progression, metastasis, and recurrence due to their self-renewal capacity and resistance to …

Terconazole, an azole antifungal drug, increases cytotoxicity in antimitotic drug-treated resistant cancer cells with substrate-specific P-gp inhibitory activity

JS Lee, Y Oh, JH Park, SY Kyung, HS Kim… - International Journal of …, 2022 - mdpi.com
Azole antifungal drugs have been shown to enhance the cytotoxicity of antimitotic drugs in P-
glycoprotein (P-gp)-overexpressing-resistant cancer cells. Herein, we examined two azole …

Pairs of thiol-substituted 1, 2, 4-triazole-based isomeric covalent inhibitors with tunable reactivity and selectivity

S Xu, Z Ye, S Shang, F Wang, H Zhang, L Chen… - Chinese Chemical …, 2024 - Elsevier
Covalent bioactive compounds are successfully used in clinic and attracted intense research
efforts in the fundamental study as well as drug development. The advantageous effects of …

Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma

S Wang, Y Li, Y Lin, J Li, L Guo, H Wang, X Lin, Z Liu… - Scientific Reports, 2024 - nature.com
Clear cell renal cell carcinoma (ccRCC) is a malignant tumor of the urinary system. To
explore the potential mechanisms of DHODH in ccRCC, we analyzed its molecular …

Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer

S Shah, P Famta, A Sharma, R Kumar… - Drug Delivery and …, 2024 - Springer
The current advent explores the potential of itraconazole (ITR) in prostate cancer (PCa), by
its incorporation into albumin nanoparticles (NP). ITR as a repurposed moiety has displayed …

A review of hedgehog signaling in radioresistant esophageal cancer: potential treatment target

L Ma, Y Wang, P Chen, S Wu - Technology in Cancer …, 2023 - journals.sagepub.com
Esophageal cancer is one of the most lethal malignancies worldwide. For locally advanced
diseases, radiotherapy is the main treatment. The survival rates, however, are still appalling …

Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics

T Rustandi, AM Yumassik, FS Ilahi, R Alfian… - Frontiers in …, 2024 - frontiersin.org
The prevalence of cancer in 2022, according to World Health Organization (WHO) data, is
20 million new cases and 9.7 deaths. The comparison of death rates based on gender is that …